國立虎尾科技大學 |

Myasthenia Gravis and Related Disorders

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Myasthenia Gravis and Related Disorders/ edited by Henry J. Kaminski, Linda L. Kusner.
other author:	Kaminski, Henry J.
Description:	XIII, 353 p. 52 illus., 15 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Neurology . -
Online resource:	https://doi.org/10.1007/978-3-319-73585-6
ISBN:	9783319735856

Myasthenia Gravis and Related Disorders
Myasthenia Gravis and Related Disorders[electronic resource] /edited by Henry J. Kaminski, Linda L. Kusner. - 3rd ed. 2018. - XIII, 353 p. 52 illus., 15 illus. in color.online resource. - Current Clinical Neurology,1559-0585. - Current Clinical Neurology,.

Chapter 1. Neuromuscular Junction Physiology and Pathophysiology -- Chapter 2. Acetylcholine Receptor Structure -- Chapter 3. Immunopathogenesis of Myasthenia Gravis -- Chapter 4. Animal Models of Myasthenia Gravis for Preclinical Evaluation -- Chapter 5. Epidemiology and Genetics of Myasthenia Gravis -- Chapter 6. Clinical Presentations of Myasthenia Gravis -- Chapter 7. Ocular Myasthenia -- Chapter 8. Thymoma-associated Myasthenia Gravis -- Chapter 9. Electrodiagnosis of Neuromuscular Junction Disorders -- Chapter 10. Autoantibody Testing in the Diagnosis and Management of Autoimmune Disorders of Neuromuscular Transmission and Related Diseases -- Chapter 11. Treatment of Myasthenia Gravis -- Chapter 12. Neurocritical Care of Myasthenic Crisis -- Chapter 13. Thymectomy for Non-thymomatous Myasthenia Gravis -- Chapter 14. Lambert-Eaton Syndrome -- Chapter 15 Acquired Neuromyotonia -- Chapter 16. Congenital Myasthenic Syndromes -- Chapter 17. Toxic Neuromuscular Transmission Disorders -- Chapter 18. Predictors of Psychological Health in Myasthenia Gravis -- Chapter 19. Myasthenia Gravis: Classification and Outcome Measurements -- Chapter 20. Emerging Therapeutics for Myasthenia Gravis -- Chapter 21. Clinical Trial Design for Myasthenia Gravis.

The third edition of this important, gold-standard title outlines a range of significant advances in the study and understanding of myasthenia gravis. The overarching goal of this new edition is identical to the first and second -- to provide the clinician and the scientist with a common resource for understanding the profound achievements in the clinical, translational, and basic sciences of neuromuscular transmission disorders. In addition to several new authors and an extensive update of all chapters, this third edition includes summaries of pre-clinical research standards for autoimmune MG, along with a broad summary of MG clinical trial performance. The now greater understanding of the clinical presentation of MuSK-related MG and identification of potential new autoantigens, including LRP-4, is discussed. The development of treatment guidelines by groups in Japan, the United Kingdom, Germany, and an international consortium is also outlined. Myasthenia Gravis and Related Disorders, Third Edition, is an invaluable resource for meeting the many and varied needs of clinicians who treat patients with myasthenia gravis.

ISBN: 9783319735856

Standard No.: 10.1007/978-3-319-73585-6doiSubjects--Topical Terms:

1253459
Neurology .

LC Class. No.: RC346-429.2

Dewey Class. No.: 616.8

Myasthenia Gravis and Related Disorders
LDR:03792nam a22004095i 4500 001 997891
003 DE-He213
005 20200630044321.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319735856 $9 978-3-319-73585-6
024 7 $a 10.1007/978-3-319-73585-6 $2 doi
035 $a 978-3-319-73585-6
050 4 $a RC346-429.2
072 7 $a MJN $2 bicssc
072 7 $a MED056000 $2 bisacsh
072 7 $a MKJ $2 thema
082 0 4 $a 616.8 $2 23
245 1 0 $a Myasthenia Gravis and Related Disorders $h [electronic resource] / $c edited by Henry J. Kaminski, Linda L. Kusner.
250 $a 3rd ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Humana, $c 2018.
300 $a XIII, 353 p. 52 illus., 15 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Current Clinical Neurology, $x 1559-0585
505 0 $a Chapter 1. Neuromuscular Junction Physiology and Pathophysiology -- Chapter 2. Acetylcholine Receptor Structure -- Chapter 3. Immunopathogenesis of Myasthenia Gravis -- Chapter 4. Animal Models of Myasthenia Gravis for Preclinical Evaluation -- Chapter 5. Epidemiology and Genetics of Myasthenia Gravis -- Chapter 6. Clinical Presentations of Myasthenia Gravis -- Chapter 7. Ocular Myasthenia -- Chapter 8. Thymoma-associated Myasthenia Gravis -- Chapter 9. Electrodiagnosis of Neuromuscular Junction Disorders -- Chapter 10. Autoantibody Testing in the Diagnosis and Management of Autoimmune Disorders of Neuromuscular Transmission and Related Diseases -- Chapter 11. Treatment of Myasthenia Gravis -- Chapter 12. Neurocritical Care of Myasthenic Crisis -- Chapter 13. Thymectomy for Non-thymomatous Myasthenia Gravis -- Chapter 14. Lambert-Eaton Syndrome -- Chapter 15 Acquired Neuromyotonia -- Chapter 16. Congenital Myasthenic Syndromes -- Chapter 17. Toxic Neuromuscular Transmission Disorders -- Chapter 18. Predictors of Psychological Health in Myasthenia Gravis -- Chapter 19. Myasthenia Gravis: Classification and Outcome Measurements -- Chapter 20. Emerging Therapeutics for Myasthenia Gravis -- Chapter 21. Clinical Trial Design for Myasthenia Gravis.
520 $a The third edition of this important, gold-standard title outlines a range of significant advances in the study and understanding of myasthenia gravis. The overarching goal of this new edition is identical to the first and second -- to provide the clinician and the scientist with a common resource for understanding the profound achievements in the clinical, translational, and basic sciences of neuromuscular transmission disorders. In addition to several new authors and an extensive update of all chapters, this third edition includes summaries of pre-clinical research standards for autoimmune MG, along with a broad summary of MG clinical trial performance. The now greater understanding of the clinical presentation of MuSK-related MG and identification of potential new autoantigens, including LRP-4, is discussed. The development of treatment guidelines by groups in Japan, the United Kingdom, Germany, and an international consortium is also outlined. Myasthenia Gravis and Related Disorders, Third Edition, is an invaluable resource for meeting the many and varied needs of clinicians who treat patients with myasthenia gravis.
650 0 $a Neurology . $3 1253459
650 0 $a Neurosciences. $3 593561
650 0 $a Immunology. $3 592892
650 0 $a Respiratory organs—Diseases. $3 1254083
650 1 4 $a Neurology. $3 593894
650 2 4 $a Pneumology/Respiratory System. $3 668561
700 1 $a Kaminski, Henry J. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 897383
700 1 $a Kusner, Linda L. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1202924
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319735849
776 0 8 $i Printed edition: $z 9783319735863
776 0 8 $i Printed edition: $z 9783030088156
830 0 $a Current Clinical Neurology, $x 1559-0585 $3 1255443
856 4 0 $u https://doi.org/10.1007/978-3-319-73585-6
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)